Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
Status:
Terminated
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This clinical trial is studying how well giving cilengitide together with sunitinib malate
works in treating patients with advanced solid tumors or glioblastoma multiforme. Cilengitide
and sunitinib malate may stop the growth of tumor cells by blocking blood flow to the tumor.
Giving cilengitide together with sunitinib malate may kill more tumor cells. Studying samples
of blood in the laboratory from patients receiving cilengitide and sunitinib malate may help
doctors understand the effect of these drugs on biomarkers.